Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions
- PMID: 2968204
- PMCID: PMC1541672
Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions
Abstract
We performed experiments to investigate whether immune complexes opsonized with C3b and iC3b transferred from CR1 on one erythrocyte to CR1 on others, and studied the effect of variation in erythrocyte CR1 number on the transfer reaction. We used populations of cells of different blood groups to study this phenomenon which were separated by differential agglutination with monoclonal anti-group antibodies. The rate of transfer of immune complexes between erythrocytes was related to CR1 concentration of both donor and recipient cells; fastest transfer occurred from donor cells of low CR1 numbers to recipient cells of high CR1. These results were not explained by a difference in the binding constant of immune complexes to erythrocytes bearing different numbers of CR1. In the absence of factor I, complexes partitioned between erythrocytes according to their relative concentrations of CR1 with no release of complexes into solution. In serum, the proportion of complexes bound to donor and recipient erythrocytes was similarly related to their respective CR1 numbers with progressive release of complexes into solution. Erythrocyte CR1 may act as a dynamic buffering system which prevents immune complexes that have bound complement from fixing to vascular endothelium.
Similar articles
-
The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.Clin Exp Immunol. 1989 Mar;75(3):329-35. Clin Exp Immunol. 1989. PMID: 2522842 Free PMC article.
-
[Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].Schweiz Med Wochenschr. 1993 Jan 23;123(3):39-43. Schweiz Med Wochenschr. 1993. PMID: 8426946 French.
-
Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).Immunology. 1985 May;55(1):97-103. Immunology. 1985. PMID: 3158597 Free PMC article.
-
The human C3b receptor (CR1).Adv Nephrol Necker Hosp. 1989;18:249-69. Adv Nephrol Necker Hosp. 1989. PMID: 2522267 Review.
-
The binding of immune complexes by the erythrocyte complement receptor 1 (CR1).Immunopharmacology. 1992 Sep-Oct;24(2):101-6. doi: 10.1016/0162-3109(92)90016-6. Immunopharmacology. 1992. PMID: 1473961 Review.
Cited by
-
Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases.Immunol Rev. 2023 Jan;313(1):71-90. doi: 10.1111/imr.13131. Epub 2022 Sep 11. Immunol Rev. 2023. PMID: 36089777 Free PMC article. Review.
-
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.J Clin Invest. 1989 Sep;84(3):962-70. doi: 10.1172/JCI114259. J Clin Invest. 1989. PMID: 2527255 Free PMC article.
-
Complement deficiency and immune complex disease.Springer Semin Immunopathol. 1994;15(4):397-416. doi: 10.1007/BF01837367. Springer Semin Immunopathol. 1994. PMID: 8153874 Review. No abstract available.
-
Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations.PLoS One. 2015 Mar 9;10(3):e0120826. doi: 10.1371/journal.pone.0120826. eCollection 2015. PLoS One. 2015. PMID: 25751254 Free PMC article.
-
Complement in the pathogenesis of Alzheimer's disease.Semin Immunopathol. 2018 Jan;40(1):113-124. doi: 10.1007/s00281-017-0662-9. Epub 2017 Nov 13. Semin Immunopathol. 2018. PMID: 29134267 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources